Evidence map›Paper›PMID 37174674›Full record

ArticleCells2023

Metabolic Syndrome Induces Epigenetic Alterations in Mitochondria-Related Genes in Swine Mesenchymal Stem Cells.

Kamalnath S Rajagopalan, Sara Kazeminia, Logan M Glasstetter, Rahele A Farahani, Xiang-Yang Zhu, Hui Tang, Kyra L Jordan, Alejandro R Chade, Amir Lerman, Lilach O Lerman and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Kamalnath S RajagopalanDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA.
Sara KazeminiaDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA.
Logan M GlasstetterDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA.
Rahele A FarahaniDivision of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN 55905, USA.
Xiang-Yang ZhuDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA.
Hui TangDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA.
Kyra L JordanDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA.
Alejandro R ChadeDepartment of Medical Pharmacology and Physiology and Department of Medicine, University of Missouri-Columbia, Columbia, MO 65211, USA.
Amir LermanDepartment of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA.
Lilach O LermanDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0002-3271-3887
Alfonso EirinDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0002-3864-9644
Mayo Clinic · USMayo Clinic in Arizona · USUniversity of Missouri · US

Funding

Microcirculation in Renovascular HypertensionR01HL095638 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI CHADE, ALEJANDRO ROBERTO · 2010 to 2021
$3.9M
Obesity-induced dysfunction of human MSC in peripheral microvascular repairR01HL158691 · NHLBI · MAYO CLINIC ROCHESTER · PI Alfonso Eirin, Lilach O Lerman · 2022 to 2026
$3.4M
Obesity-induced mesenchymal stem cell senescenceR01DK120292 · NIDDK · MAYO CLINIC ROCHESTER · PI LERMAN, LILACH O · 2019 to 2022
$2.6M
Role of mitochondrial microRNAs (mitomiRs) in endogenous renal repairR01DK129240 · NIDDK · MAYO CLINIC ROCHESTER · PI Alfonso Eirin · 2023 to 2026
$1.8M
Role of mitochondrial microRNAs (mitomiRs) in endogenous renal repairR56DK129240 · NIDDK · MAYO CLINIC ROCHESTER · PI EIRIN, ALFONSO · 2021 to 2021
$100k
NHLBI NIH HHS R01 HL095638NHLBI NIH HHS R01 HL158691NIDDK NIH HHS R01 DK120292NIDDK NIH HHS R01 DK129240NIDDK NIH HHS R56 DK129240
6 · The paper itself

Abstract

Autologous mesenchymal stem/stromal cells (MSCs) have demonstrated important therapeutic effects in several diseases. Cardiovascular risk factors may impair MSC mitochondrial structure and function, but the underlying mechanisms remain unknown. We hypothesized that metabolic syndrome (MetS) induces epigenetic alterations in mitochondria-related genes in swine MSCs. Pigs were fed a Lean or MetS diet (

Indexed as

Mesenchymal Stem CellsMetabolic SyndromeAnimalsDietEpigenesis, GeneticMitochondriaSwineDNA methylationepigeneticsMeDIP-seqmesenchymal stem cellsmetabolic syndromemitochondria

Identifiers

PMID37174674
PMCPMC10177475
OpenAlexW4367317420

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.